UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,000 | -31.0% | 74 | 0.0% | 0.00% | – |
Q2 2022 | $42,000 | -49.4% | 74 | 0.0% | 0.00% | – |
Q1 2022 | $83,000 | -88.2% | 74 | -84.6% | 0.00% | – |
Q4 2021 | $704,000 | +166.7% | 482 | +447.7% | 0.00% | – |
Q3 2021 | $264,000 | -80.8% | 88 | -70.4% | 0.00% | – |
Q2 2021 | $1,378,000 | -94.9% | 297 | -93.5% | 0.00% | – |
Q1 2021 | $27,282,000 | -20.5% | 4,547 | -30.6% | 0.00% | – |
Q4 2020 | $34,327,000 | +25.2% | 6,551 | -17.3% | 0.00% | – |
Q3 2020 | $27,424,000 | +160.9% | 7,926 | +554.5% | 0.00% | – |
Q2 2020 | $10,511,000 | -79.6% | 1,211 | -86.4% | 0.00% | – |
Q1 2020 | $51,463,000 | +111.9% | 8,873 | +163.4% | 0.00% | – |
Q4 2019 | $24,290,000 | -2.6% | 3,369 | -17.6% | 0.00% | – |
Q3 2019 | $24,931,000 | -5.8% | 4,087 | +46.6% | 0.00% | – |
Q2 2019 | $26,476,000 | -39.0% | 2,787 | -48.0% | 0.00% | – |
Q1 2019 | $43,429,000 | +2868.5% | 5,355 | +5850.0% | 0.00% | – |
Q4 2018 | $1,463,000 | -45.6% | 90 | -45.5% | 0.00% | – |
Q3 2018 | $2,688,000 | – | 165 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |